
Atossa Therapeutics, Inc.
USD1.96
-0.02 (-1.01%)
CEO
Steven C. Quay
IPO Date
2012-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.99
Prev. Close
$1.98
Day Low
$1.94
Day High
$1.99
52W Low
$1.70
52W High
$19.35
Market Cap
$0.02B
Volume
0.04M
| -4.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -33.1% | -31.3% | 0.00 | 17.61 | -3.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -22.9% | -21.8% | 0.00 | 21.23 | -2.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -14.9% | -14.6% | 0.00 | 45.18 | -9.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -65.6% | -41.6% | 0.00 | 2.73 | -0.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -131.0% | -118.9% | 0.00 | 10.83 | -0.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -129.5% | -97.3% | 0.00 | 3.96 | -0.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -117.1% | -99.5% | 0.00 | 6.45 | -0.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -205.6% | -153.7% | 0.00 | 3.11 | -0.7 |
| -1.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -17.5% | -15.0% | 0.00 | 6.77 | -3.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -14.6% | -13.1% | 0.00 | 9.17 | -3.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.3% | -9.5% | 0.00 | 12.67 | -3.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.9% | -8.3% | 0.00 | 14.99 | -4.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -9.8% | -9.1% | 0.00 | 13.30 | -6.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -7.5% | -7.0% | 0.00 | 14.35 | -6.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.9% | -6.5% | 0.00 | 16.34 | -10.7 |
| 31 Dec 2023 | Q4 | -77.8% | -43077.8% | -8.5% | -8.1% | 0.00 | 17.61 | -3.6 |